efc14-136_sc13da.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 6)*
HEALTH MANAGEMENT ASSOCIATES, INC.
(Name of Issuer)
Class A Common Stock, par value $0.01 per share
(Title of Class of Securities)
421933102
(CUSIP Number)
Mark Horowitz
Glenview Capital Management, LLC
767 Fifth Avenue, 44th Floor
New York, NY 10153
(212) 812-4700
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
January 27, 2014
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ]
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
SCHEDULE 13D
|
| |
|
|
|
CUSIP No.: 421933102
|
|
Page 2 of 7 Pages
|
|
1.
|
Names of Reporting Persons.
GLENVIEW CAPITAL MANAGEMENT, LLC
|
|
2.
|
Check the Appropriate Box if a Member of a Group
(a) [ ]
(b) [ ]
|
|
3.
|
SEC Use Only
|
| 4. |
Source of Funds (See Instructions)
AF
|
| 5. |
Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)
[ ]
|
|
6.
|
Citizenship or Place of Organization
Delaware
|
|
Number of
Shares
Beneficially
Owned by Each
Reporting
Person With
|
7.
|
Sole Voting Power
|
0
|
|
8.
|
Shared Voting Power
|
|
|
9.
|
Sole Dispositive Power
|
|
|
10.
|
Shared Dispositive Power
|
|
|
11.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
|
12.
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
[ ]
|
|
13.
|
Percent of Class Represented by Amount in Row (11)
0.0%
|
|
14.
|
Type of Reporting Person:
OO
|
|
SCHEDULE 13D
|
| |
|
|
|
CUSIP No.: 421933102
|
|
Page 3 of 7 Pages
|
|
1.
|
Names of Reporting Persons.
LAWRENCE M. ROBBINS
|
|
2.
|
Check the Appropriate Box if a Member of a Group
(a) [ ]
(b) [ ]
|
|
3.
|
SEC Use Only
|
| 4. |
Source of Funds (See Instructions)
AF
|
| 5. |
Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)
[ ]
|
|
6.
|
Citizenship or Place of Organization
United States of America
|
|
Number of
Shares
Beneficially
Owned by Each
Reporting
Person With
|
7.
|
Sole Voting Power
|
0
|
|
8.
|
Shared Voting Power
|
|
|
9.
|
Sole Dispositive Power
|
|
|
10.
|
Shared Dispositive Power
|
|
|
11.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
|
12.
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
[ ]
|
|
13.
|
Percent of Class Represented by Amount in Row (11)
0.0%
|
|
14.
|
Type of Reporting Person:
IN, HC
|
|
SCHEDULE 13D
|
| |
|
|
|
|
|
Page 4 of 7 Pages
|
|
Item 1.
|
Security and Issuer
|
This Amendment No. 6 amends and supplements the information set forth in the Schedule 13D filed by the Reporting Persons with the United States Securities and Exchange Commission (the “SEC”) on May 6, 2013, as amended by Amendment No. 1 filed on May 28, 2013, Amendment No. 2 filed on June 11, 2013, Amendment No. 3 filed on June 25, 2013, Amendment No. 4 filed on August 20, 2013, and Amendment No. 5 filed on November 15, 2013 (the “Schedule 13D”) relating to the Class A Common Stock, par value $0.01 per share (the “Shares”), of Health Management Associates, Inc. (the “Issuer”), whose principal executive offices are located at 811 Pelican Bay Boulevard, Suite 500, Naples, Florida 34108-2710. All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D.
|
Item 4.
|
Purpose of Transaction
|
Item 4 of the Schedule 13D is hereby amended and supplemented as follows:
On January 27, 2014, Community Health Systems, Inc. (“CYH”) announced that it had completed its acquisition of the Issuer. In connection with this acquisition, the Reporting Persons received, among other consideration, 2,621,125 shares of CYH common stock in exchange for the 37,757,583 Shares beneficially owned by the Reporting Persons as of January 27, 2014, at an exchange rate of 0.06942 shares of CYH common stock per Share and adjusted for the cash received in lieu of fractional shares of CYH common stock.
|
Item 5.
|
Interest in Securities of the Issuer
|
Item 5 of the Schedule D is hereby amended and supplemented as follows:
(a, b) Each of Glenview Capital Management and Mr. Robbins may be deemed to share voting and dispositive power over 0 Shares, which equates to 0.0% of the total number of Shares outstanding.
(c) The response to Item 4 is incorporated by reference herein.
(d) This Item 5(e) is not applicable.
(e) On January 27, 2014, each of the Reporting Persons ceased to be the beneficial owner of more than five percent of the Shares.
|
Item 7.
|
Material to be Filed as Exhibits.
|
| |
Exhibit A:
|
Joint Filing Agreement
|
| |
Exhibit B:
|
Power of Attorney
|
|
SCHEDULE 13D
|
| |
|
|
|
|
|
Page 5 of 7 Pages
|
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| |
GLENVIEW CAPITAL MANAGEMENT, LLC
|
|
| |
|
|
|
| |
|
|
|
|
|
By:
|
/s/ Mark J. Horowitz |
|
| |
Name: |
Mark J. Horowitz
|
|
| |
Title: |
President of Glenview Capital Management, LLC |
|
| |
|
|
| |
|
|
|
| |
|
|
|
|
|
By:
|
/s/ Mark J. Horowitz |
|
| |
Name: |
Mark J. Horowitz
|
|
| |
Title: |
Attorney-in-fact for Lawrence M. Robbins |
|
January 29, 2014
Attention: Intentional misstatements or omissions of act constitute federal violations (see 18 U.S.C. 1001).
|
SCHEDULE 13D
|
| |
|
|
|
|
|
Page 6 of 7 Pages
|
EXHIBIT A
JOINT FILING AGREEMENT
The undersigned hereby agree that the statement on Schedule 13D with respect to the Class A Common Stock of Health Management Associates, Inc. dated as of January 29, 2014 is, and any amendments thereto (including amendments on Schedule 13G) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
| |
GLENVIEW CAPITAL MANAGEMENT, LLC
|
|
| |
|
|
|
| |
|
|
|
|
|
By:
|
/s/ Mark J. Horowitz |
|
| |
Name: |
Mark J. Horowitz
|
|
| |
Title: |
President of Glenview Capital Management, LLC |
|
| |
|
|
| |
|
|
|
| |
|
|
|
|
|
By:
|
/s/ Mark J. Horowitz |
|
| |
Name: |
Mark J. Horowitz
|
|
| |
Title: |
Attorney-in-fact for Lawrence M. Robbins |
|
January 29, 2014
|
SCHEDULE 13D
|
| |
|
|
|
|
|
Page 7 of 7 Pages
|
EXHIBIT B
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENT, that I, Lawrence M. Robbins, hereby make, constitute and appoint Mark J. Horowitz, acting individually, as my agent and attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as Chief Executive Officer or in other capacities of Glenview Capital Management, LLC, a Delaware limited liability company, and each of its affiliates or entities advised or controlled by me or Glenview Capital Management, LLC, all documents, certificates, instruments, statements, filings and agreements (“documents”) to be filed with or delivered to any foreign or domestic governmental or regulatory body or required or requested by any other person or entity pursuant to any legal or regulatory requirement relating to the acquisition, ownership, management or disposition of securities, futures contracts or other investments, and any other documents relating or ancillary thereto, including, without limitation, all documents relating to filings with the United States Securities and Exchange Commission (the “SEC”) pursuant to the Securities Act of 1933, as amended, or the Securities and Exchange Act of 1934, as amended (the “Act”), and the rules and regulations promulgated thereunder, including, without limitation: (1) all documents relating to the beneficial ownership of securities required to be filed with the SEC pursuant to Section 13(d) or Section 16(a) of the Act, including, without limitation: (a) any acquisition statements on Schedule 13D or Schedule 13G and any amendments thereto, (b) any joint filing agreements pursuant to Rule 13d-1(k), and (c) any initial statements of, or statements of changes in, beneficial ownership of securities on Form 3, Form 4 or Form 5 and (2) any information statements on Form 13F required to be filed with the SEC pursuant to Section 13(f) of the Act.
All past acts of the attorney-in-fact in furtherance of the foregoing are hereby ratified and confirmed.
This Power of Attorney shall remain in effect until revoked, in writing, by the undersigned.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney, this 10th day of February, 2009.
/s/ Lawrence M. Robbins
-------------------------------
Lawrence M. Robbins